Details for New Drug Application (NDA): 204041
✉ Email this page to a colleague
The generic ingredient in ZOLMITRIPTAN is zolmitriptan. There are twenty drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the zolmitriptan profile page.
Summary for 204041
Tradename: | ZOLMITRIPTAN |
Applicant: | Ajanta Pharma Ltd |
Ingredient: | zolmitriptan |
Patents: | 0 |
Pharmacology for NDA: 204041
Mechanism of Action | Serotonin 1b Receptor Agonists Serotonin 1d Receptor Agonists |
Suppliers and Packaging for NDA: 204041
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 204041 | ANDA | Ajanta Pharma USA Inc. | 27241-021 | 27241-021-68 | 1 BLISTER PACK in 1 CARTON (27241-021-68) / 6 TABLET in 1 BLISTER PACK |
ZOLMITRIPTAN | zolmitriptan | TABLET;ORAL | 204041 | ANDA | Ajanta Pharma USA Inc. | 27241-022 | 27241-022-38 | 1 BLISTER PACK in 1 CARTON (27241-022-38) / 3 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 2.5MG | ||||
Approval Date: | May 20, 2016 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | May 20, 2016 | TE: | AB | RLD: | No |
Complete Access Available with Subscription